Biocon Ltd on Monday said its arm Biocon Pharma Ltd has received approval from the US health regulator for its generic version of Everolimus tablets for oral suspension used in the treatment of ...
A female patient in the 70s presented with bilateral flank pain and haematuria. Evaluation confirmed tuberous sclerosis complex (TSC) with cutaneous findings, a giant renal angiomyolipoma (AML) in the ...
RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced ...
Everolimus TFOS is a kinase inhibitor indicated in adult and pediatric patients aged one year and older with tuberous sclerosis complex for the treatment of subependymal giant cell astrocytoma that ...
MAPLE GROVE, Minn., Aug. 5, 2024 /PRNewswire/ -- Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the recent launch of TORPENZ™ (everolimus) Tablets in 2.5 mg, 5 mg, 7.5 mg and 10 mg ...
In an exchange filing, the company said the approval covers Everolimus Tablets for Oral Suspension in 2 mg, 3 mg and 5 mg strengths.
BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved ...
Biocon’s arm Biocon Pharma has received approval from the US health regulator for its generic version of everolimus tablets for oral suspension used in the treatment of tuberous sclerosis complex, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results